BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31140920)

  • 21. Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital.
    Schoevaerdts D; Bogaerts P; Grimmelprez A; de Saint-Hubert M; Delaere B; Jamart J; Swine C; Glupczynski Y
    BMC Infect Dis; 2011 Jan; 11():12. PubMed ID: 21226923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and risk factors for carriage of extended-spectrum β-lactamase-producing enterobacteriaceae in rehabilitation wards in France.
    Grall-Zahar I; Rucly S; Billard-Pomares T; Gasnier-Besnardeau K; Al Mouft O; Zahar JR; Zirnhelt I
    Infect Dis Now; 2022 Oct; 52(7):403-407. PubMed ID: 35914711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome.
    Emmanuel Martinez A; Widmer A; Frei R; Pargger H; Tuchscherer D; Marsch S; Egli A; Tschudin-Sutter S
    Infect Control Hosp Epidemiol; 2019 Apr; 40(4):408-413. PubMed ID: 30786948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying risk of disease due to extended-spectrum β-lactamase producing Enterobacteriaceae in patients who are colonized at ICU admission.
    Razazi K; Rosman J; Phan AD; Carteaux G; Decousser JW; Woerther PL; de Prost N; Brun-Buisson C; Mekontso Dessap A
    J Infect; 2020 May; 80(5):504-510. PubMed ID: 32142931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colonization of patients hospitalized at orthopedic department of tertiary hospital in Uganda with extended-spectrum beta-lactamase-producing enterobacterales.
    Bizimana J; Ndayisenga J; Kajumbura H; Mulepo P; Christine NF
    Antimicrob Resist Infect Control; 2023 Apr; 12(1):26. PubMed ID: 37005681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso.
    Ouedraogo AS; Sanou M; Kissou A; Sanou S; Solaré H; Kaboré F; Poda A; Aberkane S; Bouzinbi N; Sano I; Nacro B; Sangaré L; Carrière C; Decré D; Ouégraogo R; Jean-Pierre H; Godreuil S
    BMC Infect Dis; 2016 Jul; 16():326. PubMed ID: 27400864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Considerable rate of putative virulent phylo-groups in fecal carriage of extended-spectrum β-lactamase producing Escherichia coli.
    Aghamohammad S; Badmasti F; Shirazi AS; Dabiri H; Solgi H; Sabeti S; Shahcheraghi F
    Infect Genet Evol; 2019 Sep; 73():184-189. PubMed ID: 31054921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colonization by fecal extended-spectrum β-lactamase-producing Enterobacteriaceae and surgical site infections in patients with cancer undergoing gastrointestinal and gynecologic surgery.
    Golzarri MF; Silva-Sánchez J; Cornejo-Juárez P; Barrios-Camacho H; Chora-Hernández LD; Velázquez-Acosta C; Vilar-Compte D
    Am J Infect Control; 2019 Aug; 47(8):916-921. PubMed ID: 30850249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization.
    Friedmann R; Raveh D; Zartzer E; Rudensky B; Broide E; Attias D; Yinnon AM
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):534-42. PubMed ID: 19419270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.
    Razazi K; Derde LP; Verachten M; Legrand P; Lesprit P; Brun-Buisson C
    Intensive Care Med; 2012 Nov; 38(11):1769-78. PubMed ID: 22893223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal Carriage of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Strains Is Associated with Worse Outcome in Patients Hospitalized in the Pediatric Oncology Unit of Beni-Messous Hospital in Algiers, Algeria.
    Medboua-Benbalagh C; Touati A; Kermas R; Gharout-Sait A; Brasme L; Mezhoud H; Touati D; Guillard T; de Champs C
    Microb Drug Resist; 2017 Sep; 23(6):757-763. PubMed ID: 28095119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
    Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes and prognostic factors in bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a meta-analysis.
    Jiang AM; Liu N; Zhao R; Zheng HR; Chen X; Fan CX; Zhang R; Zheng XQ; Fu X; Yao Y; Tian T
    Ann Clin Microbiol Antimicrob; 2020 Nov; 19(1):53. PubMed ID: 33228668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Prevalence of Faecal Carriage of ESBL-Producing Enterobacteriaceae among Children in Dar es Salaam, Tanzania.
    Tellevik MG; Blomberg B; Kommedal Ø; Maselle SY; Langeland N; Moyo SJ
    PLoS One; 2016; 11(12):e0168024. PubMed ID: 27936054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rectal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae among hospitalised neonates in a neonatal intensive care unit in Fez, Morocco.
    Arhoune B; Oumokhtar B; Hmami F; Barguigua A; Timinouni M; El Fakir S; Chami F; Bouharrou A
    J Glob Antimicrob Resist; 2017 Mar; 8():90-96. PubMed ID: 28039104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards.
    Ruppé E; Pitsch A; Tubach F; de Lastours V; Chau F; Pasquet B; Lucet JC; Andremont A; Fantin B
    Eur J Clin Microbiol Infect Dis; 2012 Mar; 31(3):319-25. PubMed ID: 21660500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
    Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
    Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
    Nakai H; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Yamagishi Y; Mikamo H
    J Infect Chemother; 2016 May; 22(5):319-26. PubMed ID: 26968486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae in high-risk patients in an Irish tertiary care hospital.
    O'Connell N; Keating D; Kavanagh J; Schaffer K
    J Hosp Infect; 2015 Jun; 90(2):102-7. PubMed ID: 25799484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India.
    Mittal G; Gaind R; Kumar D; Kaushik G; Gupta KB; Verma PK; Deb M
    BMC Microbiol; 2016 Jul; 16(1):138. PubMed ID: 27392139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.